Efficacy and Safety of IDegLira Versus Basal-Bolus Insulin Therapy in Patients With Type 2 Diabetes Uncontrolled on Metformin and Basal Insulin: The DUAL VII Randomized Clinical Trial - Concepedia

Concepedia

Publication | Open Access

Efficacy and Safety of IDegLira Versus Basal-Bolus Insulin Therapy in Patients With Type 2 Diabetes Uncontrolled on Metformin and Basal Insulin: The DUAL VII Randomized Clinical Trial

DOI Full Paper Access

179

Citations

20

References

2018

Year

Liana K. Billings, Ankur Doshi, D. Gouet, Alejandra Oviedo, Helena W. Rodbard, Nikolaοs Tentolouris, Randi Grøn, Natalie Halladin, Esteban Jódar

Abstract

In patients with uncontrolled type 2 diabetes on IGlar U100 and metformin, IDegLira treatment elicited HbA<sub>1c</sub> reductions comparable to basal-bolus, with statistically superior lower hypoglycemia rates and weight loss versus weight gain.

References

	Year	Citations

Page 1